1-5 of 5
Steven Tau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer

Available to Purchase
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti, Patricia C. Muskus, Alyssa M. Roberts, Melissa M. Carmichael, Lauren Cressey, Christo Philip C. Dragnev, Eugene Demidenko, Riley A. Hampsch, Shannon M. Soucy, Fred W. Kolling, Kimberley S. Samkoe, James V. Alvarez, Arminja N. Kettenbach, Todd W. Miller
Journal: Cancer Research
Cancer Res (2025) 85 (6): 1145–1161.
https://doi.org/10.1158/0008-5472.CAN-24-1204
Published: 14 March 2025
View articletitled, Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Open the PDF for Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PO4-23-08: Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer

Free
Nicole Traphagen, Gary Schwartz, Steven Tau, Alyssa Roberts, Amanda Jiang, Sarah Hosford, Jonathan Marotti, Abigail Goen, Bianca Romo, Anneka Johnson, Emily Duffy, Eugene Demidenko, Paul Heverly, Yaron Mosesson, Shannon Soucy, Fred Kolling, Todd Miller
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-23-08.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-23-08
Published: 02 May 2024
View articletitled, Abstract PO4-23-08: Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer
Journal Articles

Abstract PO4-01-14: Effects of neoadjuvant endocrine therapy on early-stage breast cancer: a retrospective cohort study of patients during the COVID19 pandemic

Free
Mary Chamberlin, Todd Miller, Marie Anne Christine Buteau, Steven Tau
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-01-14.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-01-14
Published: 02 May 2024
View articletitled, Abstract PO4-01-14: Effects of neoadjuvant endocrine therapy on early-stage breast cancer: a retrospective cohort study of patients during the COVID19 pandemic
Journal Articles

Abstract PD1-01: Estrogen therapy induces R-loop-dependent DNA damage that can be enhanced by PARP inhibition to improve response in ER+ breast cancer

Free
Nicole A. Traphagen, Steven Tau, Amanda Jiang, Jason D. Wells, Sarah R. Hosford, Abigail E. Goen, Eugene Demidenko
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD1-01.
https://doi.org/10.1158/1538-7445.SABCS21-PD1-01
Published: 15 February 2022
View articletitled, Abstract PD1-01: Estrogen therapy induces R-loop-dependent DNA damage that can be enhanced by PARP inhibition to improve response in ER+ breast cancer
Journal Articles

Abstract P4-02-12: Oxidative phosphorylation and NRF2 activation mediate resistance to estrogen deprivation in ER+ breast cancer

Free
Steven Tau, Todd W. Miller
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P4-02-12.
https://doi.org/10.1158/1538-7445.SABCS21-P4-02-12
Published: 15 February 2022
View articletitled, Abstract P4-02-12: Oxidative phosphorylation and NRF2 activation mediate resistance to estrogen deprivation in ER+ breast cancer